BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Free cash flow 2018–2024
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$62.3MFY2024 · since FY2018: -$8.5M → -$62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$62.3M | +6.7% |
| FY2023 | -$66.8M | +21.7% |
| FY2022 | -$85.3M | +17.1% |
| FY2021 | -$102.9M | -96.7% |
| FY2020 | -$52.3M | -111.7% |
| FY2019 | -$24.7M | -189.5% |
| FY2018 | -$8.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice